
RAAPID INC is a leading provider of risk adjustment solutions utilizing Neuro-Symbolic AI technology to enhance healthcare decision-making. The company offers a comprehensive suite of services including HCC coding, chart review, and clinical decision support tools designed to improve the accuracy of risk adjustment coding and ensure compliance with healthcare regulations. With a focus on health plans, healthcare providers, and medical coding companies, RAAPID differentiates itself through its advanced AI capabilities that automate manual processes, thereby increasing efficiency and reducing costs. The company has established a strong market position by delivering guaranteed compliant ROI and mitigating risks associated with audits, making it a valuable partner in the healthcare ecosystem.

RAAPID INC is a leading provider of risk adjustment solutions utilizing Neuro-Symbolic AI technology to enhance healthcare decision-making. The company offers a comprehensive suite of services including HCC coding, chart review, and clinical decision support tools designed to improve the accuracy of risk adjustment coding and ensure compliance with healthcare regulations. With a focus on health plans, healthcare providers, and medical coding companies, RAAPID differentiates itself through its advanced AI capabilities that automate manual processes, thereby increasing efficiency and reducing costs. The company has established a strong market position by delivering guaranteed compliant ROI and mitigating risks associated with audits, making it a valuable partner in the healthcare ecosystem.
Founded: 2022
Headquarters: Louisville, Kentucky
Product: HITRUST-certified Neuro-Symbolic Clinical AI platform for risk adjustment and explainable HCC coding
Customers: Payers, providers, and organizations in value-based care
Latest raise: Series A $6.7M (Jan 10, 2025) led by M12
Risk adjustment, HCC coding, clinical document processing, RADV audit defense for value-based care (Medicare Advantage, ACA, ACOs, Medicaid).
2022
Healthcare AI / Healthtech
6699334.00
“M12 (Microsoft's Venture Fund) led Series A”